Wilkes David S.
SEC CIK 1842866 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BAX | Baxter International | Dir | 37.1K | — | — | 5 | 2022-05-03 | 2026-05-05 |
Most active insiders at BAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Teaff James | Pres, CCS | — | — |
| 2 | Foster Julie | Pres, Front Line Care | — | — |
| 3 | Soriano Maria Cecilia | Group Pres, ITT, Pharma | — | — |
| 4 | Carlisle Cynthia | EVP, CHRO | — | — |
| 5 | Ampofo William A. II | Dir | — | — |
| 6 | Rasul Reazur | EVP, Group Pres, Healthcare | — | — |
| 7 | Hider Andrew P. | Pres, CEO, Dir | — | — |
| 8 | Rosenbloom David S. | EVP, GC | — | — |
| 9 | Wilkes David S. | Dir | — | — |
| 10 | Wallace Steven P. | Pres, Adv. Surgery | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 16:22 | 2026-05-05 | BAX | Baxter International | Wilkes David S. | Dir | A - Grant | $0.00 | +12.8K | 37.1K | +53% | $0 | |
| 2025-05-08 | 2025-05-06 | BAX | Baxter International | Wilkes David S. | Dir | A - Grant | $0.00 | +7,183 | 23.9K | +43% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | Baxter International | Wilkes David S. | Dir | A - Grant | $0.00 | +5,952 | 16.3K | +58% | $0 | |
| 2023-05-04 | 2023-05-02 | BAX | Baxter International | Wilkes David S. | Dir | A - Grant | $0.00 | +4,573 | 10.0K | +84% | $0 | |
| 2022-05-05 | 2022-05-03 | BAX | Baxter International | Wilkes David S. | Dir | A - Grant | $0.00 | +2,706 | 5,339 | +103% | $0 |
Purchase Sale Sale after option exercise All abbreviations